ENT-A011 - Charou et al. (2024) demonstrated that ENT-A011, a novel agonist of the TrkB receptor, exerts a neurogenic and neuroprotective action in stem cell models of AD in a manner comparable to brain-derived neurotrophic factor (BDNF). Here, BDNF is linked to Alzheimer disease.